Aldo-keto reductase 1C3 Is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1103-1110

  Mantel, Alon ^a   Carpenter Mendini, Amanda B ^a   Vanbuskirk, Joanne B ^a   De Benedetto, Anna ^a   Beck, Lisa A ^a   Pentland, Alice P ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTASE 1C3; CALCIUM; CYTOKERATIN 10; LORICRIN; OXIDOREDUCTASE; PROSTAGLANDIN D2; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; BASEMENT MEMBRANE; CELL DIFFERENTIATION; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KERATINOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WESTERN BLOTTING;

EID: 84858299069     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.412     Document Type: Article

References (43)

1. Barr RM, Koro O, Francis DM et al. (1988) The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br J Pharmacol 94:773-80
2. Byrns MC, Duan L, Lee SH et al. (2010) Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. J Steroid Biochem Mol Biol 118:177-87
3. Chun KS, Lao HC, Langenbach R (2010) The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G proteindependent and {beta}-Arrestin1-dependent signaling pathways. J Biol Chem 285:39672-81
4. Dahten A, Koch C, Ernst D et al. (2008) Systemic PPARgamma ligation inhibits allergic immune response in the skin. J Invest Dermatol 128:2211-8
5. Desmond JC, Mountford JC, Drayson MT et al. (2003) The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 63:505-12
6. Eichenfield LF (2004) Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 59(Suppl 78):86-92
7. Forman BM, Tontonoz P, Chen J et al. (1995) 15-Deoxy-delta 12, 14- prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-12
8. Gingras S, Turgeon C, Brochu N et al. (2003) Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and HaCaT cells. J Steroid Biochem Mol Biol 87:167-79
9. He R, Oyoshi MK, Wang JY et al. (2010) The prostaglandin D receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge. J Allergy Clin Immunol 126:784-90
10. Hikima T, Maibach HI (2007) Gender differences of enzymatic activity and distribution of 17beta-hydroxysteroid dehydrogenase in human skin in vitro. Skin Pharmacol Physiol 20:168-74
11. Iwasaki M, Nagata K, Takano S et al. (2002) Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 119:609-15
12. Jez JM, Bennett MJ, Schlegel BP et al. (1997a) Comparative anatomy of the aldo-keto reductase superfamily. Biochem J 326(Part 3):625-35
13. Jez JM, Flynn TG, Penning TM (1997b) A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol 54:639-47
14. Kanda N, Watanabe S (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci 38:1-7
15. Konger RL, Billings SD, Prall NC et al. (2009) The EP1 subtype of prostaglandin E2 receptor: Role in keratinocyte differentiation and expression in non-melanoma skin cancer. Prostaglandins Leukot Essent Fatty Acids 81:279-90
16. Lin HK, Jez JM, Schlegel BP et al. (1997) Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. Mol Endocrinol 11:1971-84
17. Maggi Jr LB, Sadeghi H, Weigand C et al. (2000) Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: Evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Diabetes 49:346-55
18. Marin YE, Seiberg M, Lin CB (2009) Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: Possible role in keratinocytes survival. Exp Dermatol 18:611-8
19. Matsuura K, Shiraishi H, Hara A et al. (1998) Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J Biochem 124:940-5
20. Meyer M, Pahl HL, Baeuerle PA (1994) Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact 91:91-100
21. Morrow JD, Awad JA, Oates JA et al. (1992) Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol 98:812-5
22. Nakamura Y, Kawachi Y, Xu X et al. (2007) The combination of ubiquitous transcription factors AP-1 and Sp1 directs keratinocytespecific and differentiation-specific gene expression in vitro. Exp Dermatol 16:143-50
23. Penning TM, Burczynski ME, Jez JM et al. (2000) Human 3alphahydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: Functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77
24. Penning TM, Burczynski ME, Jez JM et al. (2001) Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol 171:137-49
25. Penning TM, Jin Y, Heredia VV et al. (2003) Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: A comparison of the rat and human isoforms. J Steroid Biochem Mol Biol 85:247-55
26. Penning TM, Steckelbroeck S, Bauman DR et al. (2006) Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors. Mol Cell Endocrinol 248:182-91
27. Pentland AP, Needleman P (1986) Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 77:246-51
28. Rizner TL, Lin HK, Penning TM (2003) Role of human type 3 3alphahydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. Chem Biol Interact 143-144:401-9
29. Rizner TL, Smuc T, Rupreht R et al. (2006) AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. Mol Cell Endocrinol 248:126-35
30. Sandig H, Andrew D, Barnes AA et al. (2006) 9Alpha,11beta-PGF2 and its stereoisomer PGF2alpha are novel agonists of the chemoattractant receptor, CRTH2. FEBS Lett 580:373-9
31. Satoh T, Moroi R, Aritake K et al. (2006) Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 177:2621-9
32. Schlaak JF, Buslau M, Jochum W et al. (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-9
33. Scott G, Jacobs S, Leopardi S et al. (2005) Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp Cell Res 304:407-15
34. Shibata T, Kondo M, Osawa T et al. (2002) 15-Deoxy-delta 12,14- prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277:10459-65
35. Shimura C, Satoh T, Igawa K et al. (2010) Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. Am J Pathol 176:227-37
36. Skarydova L, Zivna L, Xiong G et al. (2009) AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids. Chem Biol Interact 178:138-44
37. Straus DS, Pascual G, Li M et al. (2000) 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 97:4844-9
38. Surh I, Rundhaug J, Pavone A et al. (2011) Upregulation of the EP1 receptor for prostaglandin E(2) promotes skin tumor progression. Mol Carcinog 50:458-68
39. Suzuki-Yamamoto T, Nishizawa M, Fukui M et al. (1999) cDNA cloning, expression and characterization of human prostaglandin F synthase. FEBS Lett 462:335-40
40. Thiboutot D, Jabara S, McAllister JM et al. (2003) Human skin is a steroidogenic tissue: Steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol 120:905-14
41. Ward JE, Fernandes DJ, Taylor CC et al. (2006) The PPARgamma ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation. Pulm Pharmacol Ther 19: 39-45
42. Watanabe K, Yokoyama Y, Kokuryo T et al. (2010) 15-deoxy-delta 12,14- prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis. Am J Physiol Gastrointest Liver Physiol 298:G410-8
43. Zouboulis CC, Chen WC, Thornton MJ et al. (2007) Sexual hormones in human skin. Horm Metab Res 39:85-95